The effect of 1 year of Alagebrium and moderate-intensity exercise training on left ventricular function during exercise in seniors: a randomized controlled trial
- PMID: 27402556
- PMCID: PMC6345244
- DOI: 10.1152/japplphysiol.00021.2016
The effect of 1 year of Alagebrium and moderate-intensity exercise training on left ventricular function during exercise in seniors: a randomized controlled trial
Abstract
Sedentary aging leads to left ventricular (LV) and vascular stiffening due in part to advanced glycation end-products (AGEs) cross-linking of extracellular matrix proteins. Vigorous lifelong exercise ameliorates age-related cardiovascular (CV) stiffening and enhances exercise LV function, although this effect is limited when exercise is initiated later in life. We hypothesized that exercise training might be more effective at improving the impact of age-related CV stiffening during exercise when combined with an AGE cross-link breaker (Alagebrium). Sixty-two seniors (≥60 yr) were randomized into four groups: sedentary + placebo, sedentary + Alagebrium, exercise + placebo, and exercise + Alagebrium for 1 yr. Moderate-intensity aerobic exercise was performed 3-4 sessions/wk; controls underwent similar frequency of yoga/balance training. Twenty-four similarly-aged, lifelong exercisers (4-5 sessions/wk) served as a comparator for the effect of lifelong exercise on exercising LV function. Oxygen uptake (Douglas bags), stroke index (SI; acetylene rebreathing), and effective arterial elastance (Ea) were collected at rest and submaximal and maximal exercise. Maximum O2 uptake (23 ± 5 to 25 ± 6 ml·kg(-1)·min(-1)) increased, while SI (35 ± 11 to 39 ± 12 ml/m(2)) and Ea (4.0 ± 1.1 to 3.7 ± 1.2 mmHg·ml(-1)·m(-2)) were improved across all conditions with exercise, but remained unchanged in controls (exercise × time, P ≤ 0.018). SI or Ea were not affected by Alagebrium (medication × time, P ≥ 0.468) or its combination with exercise (interaction P ≥ 0.252). After 1 yr of exercise plus Alagebrium, exercise SI and Ea remained substantially below that of lifelong exercisers (15-24 and 9-22%, respectively, P ≤ 0.415). In conclusion, Alagebrium plus exercise had no synergistic effect on exercise LV function and failed to achieve levels associated with lifelong exercise, despite a similar exercise frequency.
Keywords: Alagebrium; exercise; left ventricular; physical training; stroke volume.
Figures




Similar articles
-
Cardiovascular effects of 1 year of alagebrium and endurance exercise training in healthy older individuals.Circ Heart Fail. 2013 Nov;6(6):1155-64. doi: 10.1161/CIRCHEARTFAILURE.113.000440. Epub 2013 Oct 15. Circ Heart Fail. 2013. PMID: 24130005 Free PMC article. Clinical Trial.
-
The effect of an advanced glycation end-product crosslink breaker and exercise training on vascular function in older individuals: a randomized factorial design trial.Exp Gerontol. 2013 Dec;48(12):1509-17. doi: 10.1016/j.exger.2013.10.009. Exp Gerontol. 2013. PMID: 24400341 Free PMC article. Clinical Trial.
-
The effect of lifelong exercise dose on cardiovascular function during exercise.J Appl Physiol (1985). 2014 Apr 1;116(7):736-45. doi: 10.1152/japplphysiol.00342.2013. Epub 2014 Jan 23. J Appl Physiol (1985). 2014. PMID: 24458750 Free PMC article.
-
Advanced glycation end-product cross-link breakers. A novel approach to cardiovascular pathologies related to the aging process.Am J Hypertens. 2004 Dec;17(12 Pt 2):23S-30S. doi: 10.1016/j.amjhyper.2004.08.022. Am J Hypertens. 2004. PMID: 15607432 Review.
-
Meta-analysis of aerobic interval training on exercise capacity and systolic function in patients with heart failure and reduced ejection fractions.Am J Cardiol. 2013 May 15;111(10):1466-9. doi: 10.1016/j.amjcard.2013.01.303. Epub 2013 Feb 21. Am J Cardiol. 2013. PMID: 23433767 Review.
Cited by
-
The effect of lifelong endurance exercise on cardiovascular structure and exercise function in women.J Physiol. 2020 Jul;598(13):2589-2605. doi: 10.1113/JP278503. Epub 2020 May 21. J Physiol. 2020. PMID: 32347540 Free PMC article.
-
Glycation in the cardiomyocyte.Vitam Horm. 2024;125:47-88. doi: 10.1016/bs.vh.2024.04.005. Epub 2024 May 24. Vitam Horm. 2024. PMID: 38997172 Free PMC article. Review.
References
-
- Arbab-Zadeh A, Dijk E, Prasad A, Fu Q, Torres P, Zhang R, Thomas JD, Palmer D, Levine BD. Effect of aging and physical activity on left ventricular compliance. Circulation : 1799–1805, 2004. - PubMed
-
- Aronson D. Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes. J Hypertens : 3–12, 2003. - PubMed
-
- Asif M, Egan J, Vasan S, Jyothirmayi GN, Masurekar MR, Lopez S, Williams C, Torres RL, Wagle D, Ulrich P, Cerami A, Brines M, Regan TJ. An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness. Proc Natl Acad Sci U S A : 2809–2813, 2000. - PMC - PubMed
-
- Banister EW, Morton RH, Fitz-Clarke J. Dose/response effects of exercise modeled from training: physical and biochemical measures. Ann Physiol Anthropol : 345–356, 1992. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous